Makers of Oluminant Withdraw Lupus Treatment Approval Request in Face of JAK-Inhibitor Health Risks
The manufacturer also expects the FDA to reject approval for the drug for the treatment of atopic dermatitis due to FDA safety cocerns.
Topic Archives: Xeljanz
-
-
Xeljanz Side Effects Linked to Higher Risk of Serious Heart Problems and Cancer, Study Finds
In addition to heart problems and cancers, researchers also saw an increased risk of opportunistic infections, like shingles.
-
Rinvoq Approved As Atopic Dermatitis Treatment Despite Heart, Cancer Risks
The move comes after the FDA held up Rinvoq approvals for months due to concerns it carried similar cancer and heart risks as Xeljanz.
-
Despite Side Effects of Xeljanz and Rinvoq, FDA Still Approves New Indications After Updated Warnings
The approvals come after new warnings about Xeljanz and Rinvoq side effects, which have been linked to cancer, blood clots and heart problems.
-
Rinvoq Warning Label Updated to Add Cancer and Heart Risks Seen With Xeljanz Side Effects
Cancer and heart risks linked to Rinvoq, Xeljanz and similar drugs have regulated them to secondary treatment options for rheumatoid arthritis.
-
Eli Lilly-Funded Study Claims Side Effects of Olumiant Do Not Warrant Same Adverse Label Warnings as Xeljanz
Study claims heart risks with Olumiant are the same as those of rheumatoid arthritis patients not taking the drug, raising questions about a class-wide warning after concerns about the side effects of Xeljanz emerged
-
Xeljanz Heart Risks May Be Similar Across Other JAK Inhibitors Like Rinvoq, Oluminant: Study
More research is needed into the link between Xeljanz and heart problems to determine how much of the risk is caused by side effects of the drugs, or the condition they are designed to treat, the researchers note
-
Opzelura Eczema Cream Investigation Announced Over Texture Problems
The issues come as similar drugs, like Xeljanz, face intense scrutiny over heart problems and cancer risks.
-
Xeljanz FDA Label Warning Update Adds Information About Risk of Cancer, Blood Clots and Heart Side Effects
-
Experts, FDA Concerned Xeljanz Heart and Cancer Problems May Affect Similar Arthritis Drugs
